Syros Pharmaceuticals Obtains $53,149,996 New Funding

  • Feed Type
  • Date
    10/27/2014
  • Company Name
    Syros Pharmaceuticals
  • Mailing Address
    480 Arsenal Street Watertown, MA 02472 USA
  • Company Description
    Syros Pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. Syros has pioneered world-leading gene control research and drug discovery capabilities.
  • Website
    http://www.syros.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $53,149,996
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy